NYSE · Medical - Instruments & Supplies

STVN (STVN) Stock

$20.29 +0.95% NYSE: STVN Healthcare

Valuation

MetricValue
Price$20.29
Market Cap$5.54B
P/E Ratio35.37
P/B Ratio3.18
P/S Ratio3.40
EPS (TTM)$0.49
52-Week High$28.00
52-Week Low$12.89
Dividend Yield0.36%

Financials & Margins

MetricValue
ROE9.02%
ROA5.27%
ROCE12.31%
Gross Margin16.07%
Operating Margin16.07%
Net Margin11.75%
Debt/Equity0.29
Current Ratio1.74

Annual Financials (USD)

Metric20212022202320242025
Revenue$844.0M$984.0M$1.1B$1.1B$1.1B
Operating Profit$162.0M$192.0M$201.0M$161.0M$183.0M
Net Profit$134.0M$143.0M$146.0M$118.0M$134.0M
EPS$0.53$0.53$0.55$0.43$0.49
Op Margin19.2%19.6%18.5%14.6%16.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.4B$1.7B$2.1B$2.3B$2.5B
Total Liabilities$577.0M$664.0M$939.0M$924.0M$1.1B
Cash$411.0M$229.0M$70.0M$98.0M$131.0M
Borrowings$244.0M$218.0M$397.0M$429.0M$471.0M

Latest News

Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026 Business Wire · Jul 21, 2026 Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last? Zacks · Jul 7, 2026 TimesSquare Mid Cap Growth Strategy Downplays Market Fears on Stevanato Group S.p.A. (STVN) Insider Monkey · Jul 1, 2026 Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last? Zacks · Jun 23, 2026 TD Cowen Initiates Stevanato at Buy With $25 Price Target MT Newswires · Jun 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$133.0M$103.0M$105.0M$156.0M$275.0M
Investing Cash Flow$-210.0M$-486.0M$-863.0M$-624.0M$-515.0M
Financing Cash Flow$6.0M$0$0$0$-6.0M
Net Cash Flow$295.0M$-182.0M$-159.0M$29.0M$44.0M
Free Cash Flow$20.0M$-140.0M$-337.0M$-158.0M$21.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA18.92
FCF Yield-0.17%
Quick Ratio1.11
Interest Coverage8.32
Return 1Y-20.69%
Return 3Y-41.37%
Return 5Y-2.33%

Ownership

Insiders Held1.65%
Institutions Held97.41%
Institutions Float Held99.04%
Institutional HolderSharesReport Date
Conestoga Capital Advisors, LLC8,491,7512026-03-31
Neuberger Berman Group, LLC4,475,4922026-03-31
Times Square Capital Management, LLC3,489,7162026-03-31
T. Rowe Price Investment Management, Inc.3,224,9082026-03-31
BAMCO Inc.2,500,4382026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATR $136.77 +2.10% 19.32 $8.73B 1.66%
AVTR $13.36 -2.34% -9.79 $9.04B 0.00%
AXSM $238.37 -1.09% 38.05 $12.27B 0.00%
BLCO $16.76 +0.48% 13.97 $5.99B 0.00%
BTSGBrightSpring Health Services, Inc. Common Stock $71.98 -1.28% 89.58 $14.13B 0.00%

About STVN

STVN stock trades at $20.29 with a market capitalization of $5.54B. The stock is valued at a price-to-earnings (P/E) ratio of 35.37, price-to-book of 3.18, price-to-sales of 3.40. Over the past 52 weeks the stock has ranged between $12.89 and $28.00, and currently trades 27.5% below its 52-week high. It pays a dividend yielding 0.36%.

On profitability, STVN generates a return on equity (ROE) of 9.02%, return on capital employed of 12.31%, an operating margin of 16.07%, a net profit margin of 11.75%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides